Fig. 1: Progression-free (PFS) and overall survival (OS) in the overall cohorts.
Kaplan–Meier curves are shown for (a) PFS and (b) OS. LEN lenalidomide, BTZ bortezomib.
Fig. 1: Progression-free (PFS) and overall survival (OS) in the overall cohorts. | Blood Cancer Journal
